(AVNT) Avient - Ratings and Ratios
Color Concentrates, Additives, Inks, Engineering Plastics
AVNT EPS (Earnings per Share)
AVNT Revenue
Description: AVNT Avient
Avient Corporation is a leading formulator of material solutions operating globally across various industries, including medical, packaging, and consumer goods. The companys two segments, Color, Additives and Inks and Specialty Engineered Materials, provide a range of products and services that cater to diverse customer needs. With a history dating back to 1885, Avient has established itself as a trusted partner for designers, assemblers, and processors of thermoplastic materials.
To further analyze Avients performance, we can look at key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow. Avients revenue has been steadily increasing over the years, driven by its diversified product portfolio and global presence. The companys gross margin has also been stable, indicating its ability to maintain pricing power and manage raw material costs. Additionally, Avients operating cash flow has been robust, enabling it to invest in growth initiatives and return capital to shareholders.
From a valuation perspective, Avients price-to-earnings (P/E) ratio of 29.23 suggests that the stock may be slightly overvalued compared to its historical average. However, its forward P/E ratio of 11.21 indicates that the market expects earnings to grow in the future. The companys return on equity (RoE) of 4.30% is relatively low, suggesting that there may be opportunities for improvement in terms of profitability. Overall, Avients financial performance and valuation multiples suggest a mixed picture, requiring further analysis to determine the stocks potential.
To make a more informed investment decision, it is essential to monitor Avients progress in terms of its strategic initiatives, such as expanding its product portfolio and enhancing its operational efficiency. Additionally, keeping an eye on industry trends, competitor activity, and macroeconomic factors will be crucial in assessing the companys future prospects. By closely tracking these factors, investors can gain a better understanding of Avients potential for long-term growth and returns.
AVNT Stock Overview
| Market Cap in USD | 2,780m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception | 1999-09-13 |
AVNT Stock Ratings
| Growth Rating | -35.9% |
| Fundamental | 51.1% |
| Dividend Rating | 60.2% |
| Return 12m vs S&P 500 | -42.1% |
| Analyst Rating | 4.33 of 5 |
AVNT Dividends
| Dividend Yield 12m | 4.22% |
| Yield on Cost 5y | 4.67% |
| Annual Growth 5y | 6.16% |
| Payout Consistency | 69.0% |
| Payout Ratio | 43.7% |
AVNT Growth Ratios
| Growth Correlation 3m | -37.6% |
| Growth Correlation 12m | -79.9% |
| Growth Correlation 5y | -23.3% |
| CAGR 5y | 0.71% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.02 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.05 |
| Sharpe Ratio 12m | -2.04 |
| Alpha | -57.59 |
| Beta | 1.420 |
| Volatility | 33.13% |
| Current Volume | 391.7k |
| Average Volume 20d | 513.1k |
| Stop Loss | 31 (-3.4%) |
| Signal | 0.31 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (118.9m TTM) > 0 and > 6% of Revenue (6% = 195.3m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.26% (prev -1.24%; Δ 24.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 255.4m > Net Income 118.9m (YES >=105%, WARN >=100%) |
| Net Debt (1.55b) to EBITDA (408.7m) ratio: 3.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (91.8m) change vs 12m ago -0.43% (target <= -2.0% for YES) |
| Gross Margin 32.63% (prev 30.39%; Δ 2.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 54.06% (prev 53.34%; Δ 0.72pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.22 (EBITDA TTM 408.7m / Interest Expense TTM 113.1m) >= 6 (WARN >= 3) |
Altman Z'' 2.57
| (A) 0.12 = (Total Current Assets 1.49b - Total Current Liabilities 737.3m) / Total Assets 6.13b |
| (B) 0.30 = Retained Earnings (Balance) 1.87b / Total Assets 6.13b |
| (C) 0.04 = EBIT TTM 251.3m / Avg Total Assets 6.02b |
| (D) 0.46 = Book Value of Equity 1.75b / Total Liabilities 3.76b |
| Total Rating: 2.57 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.14
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 3.46% = 1.73 |
| 3. FCF Margin 4.60% = 1.15 |
| 4. Debt/Equity 0.85 = 2.15 |
| 5. Debt/Ebitda 3.78 = -2.46 |
| 6. ROIC - WACC (= -2.73)% = -3.41 |
| 7. RoE 5.09% = 0.42 |
| 8. Rev. Trend 11.75% = 0.88 |
| 9. EPS Trend 33.51% = 1.68 |
What is the price of AVNT shares?
Over the past week, the price has changed by +2.69%, over one month by -7.63%, over three months by -2.14% and over the past year by -32.57%.
Is Avient a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AVNT is around 28.91 USD . This means that AVNT is currently overvalued and has a potential downside of -9.91%.
Is AVNT a buy, sell or hold?
- Strong Buy: 4
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the AVNT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 43.3 | 34.8% |
| Analysts Target Price | 43.3 | 34.8% |
| ValueRay Target Price | 31.8 | -0.8% |
Last update: 2025-10-13 02:05
AVNT Fundamental Data Overview
P/E Trailing = 23.5426
P/E Forward = 10.582
P/S = 0.8541
P/B = 1.2646
P/EG = 1.0578
Beta = 1.42
Revenue TTM = 3.25b USD
EBIT TTM = 251.3m USD
EBITDA TTM = 408.7m USD
Long Term Debt = 2.02b USD (from longTermDebt, last quarter)
Short Term Debt = 500.0k USD (from shortTermDebt, last quarter)
Debt = 2.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 4.33b USD (2.78b + Debt 2.02b - CCE 474.5m)
Interest Coverage Ratio = 2.22 (Ebit TTM 251.3m / Interest Expense TTM 113.1m)
FCF Yield = 3.46% (FCF TTM 149.8m / Enterprise Value 4.33b)
FCF Margin = 4.60% (FCF TTM 149.8m / Revenue TTM 3.25b)
Net Margin = 3.65% (Net Income TTM 118.9m / Revenue TTM 3.25b)
Gross Margin = 32.63% ((Revenue TTM 3.25b - Cost of Revenue TTM 2.19b) / Revenue TTM)
Gross Margin QoQ = 32.07% (prev 31.84%)
Tobins Q-Ratio = 0.71 (Enterprise Value 4.33b / Total Assets 6.13b)
Interest Expense / Debt = 1.67% (Interest Expense 33.8m / Debt 2.02b)
Taxrate = 24.54% (17.4m / 70.9m)
NOPAT = 189.6m (EBIT 251.3m * (1 - 24.54%))
Current Ratio = 2.03 (Total Current Assets 1.49b / Total Current Liabilities 737.3m)
Debt / Equity = 0.85 (Debt 2.02b / totalStockholderEquity, last quarter 2.37b)
Debt / EBITDA = 3.78 (Net Debt 1.55b / EBITDA 408.7m)
Debt / FCF = 10.32 (Net Debt 1.55b / FCF TTM 149.8m)
Total Stockholder Equity = 2.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.94% (Net Income 118.9m / Total Assets 6.13b)
RoE = 5.09% (Net Income TTM 118.9m / Total Stockholder Equity 2.34b)
RoCE = 5.77% (EBIT 251.3m / Capital Employed (Equity 2.34b + L.T.Debt 2.02b))
RoIC = 4.32% (NOPAT 189.6m / Invested Capital 4.39b)
WACC = 7.05% (E(2.78b)/V(4.80b) * Re(11.25%) + D(2.02b)/V(4.80b) * Rd(1.67%) * (1-Tc(0.25)))
Discount Rate = 11.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.05%
[DCF Debug] Terminal Value 71.73% ; FCFE base≈153.9m ; Y1≈189.9m ; Y5≈324.0m
Fair Price DCF = 36.15 (DCF Value 3.31b / Shares Outstanding 91.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 33.51 | EPS CAGR: -1.25% | SUE: 0.44 | # QB: 0
Revenue Correlation: 11.75 | Revenue CAGR: 1.88% | SUE: 0.80 | # QB: 0
Additional Sources for AVNT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle